Elon Musk reveals he’s taking Monzaro for weight loss in festive ‘Ozympic Santa’ post

A Slim looking Elon Musk It was revealed on Wednesday that he uses Monzaro – after previously expressing support for similar weight-loss drugs as a means of curbing the obesity epidemic in the US.

Billionaire Tesla, SpaceX and X Boss Join One social media postWhere he included a photo of himself wearing a Santa Claus suit and a wavy white beard.

Musk dubbed himself “Ozempic Santa” in an X-Post, noting that it was “like a cocaine bear, but Santa and Ozempic!”

“Technically, Monzaro, but it doesn’t have the same ring to it,” he explained.

Like Ozempic, Monjaro is also a GLP-1 inhibitor – a class of drugs developed to help people with diabetes control their blood sugar and insulin levels.

However, Americans are increasingly using GLP-1 inhibitors Successfully lost pounds.

Musk, 53, said he prefers Monjaro to Ozempic because taking “higher doses” of the latter drug makes him “fart and burp like Barney from the Simpsons.”

“Monjaro appears to have fewer side effects and is more effective,” said President-elect Donald Trump’s incoming head of the Department of Government Efficiency.

Musk has long argued for the widespread use of GLP-1 inhibitors to combat obesity — a position that clashes with Health and Human Services Secretary-designate Robert F. Kennedy Jr.’s stance on the drug.

Kennedy, 70, has argued that getting Americans to eat healthier would be a more cost-effective way to tackle the obesity crisis.

Musk has support for GLP-1 inhibitors He received praise from the generous hosts of “The View”. One of whom, Whoopi Goldberg, has even admitted to taking Monjaro.

“Elon is right on this!” Goldberg made the announcement earlier this month during a discussion on the split between the incoming DOGE chief and the HHS secretary.

The 69-year-old comedian later showed off her trim figure after telling viewers that she weighed about 300 pounds before she started taking Monjaro two years ago.

Musk, who has publicly announced that he don’t like to work outFirst Accepted to use WegoviAnother GLP-1 inhibitor, in 2022.